Evidence map›Paper›PMID 40878337›Full record

ArticleThe Indian journal of medical research2025

Evaluation of the rapid lateral flow assay (LFA) for detection of five major carbapenemase enzyme families in genotypically characterised bacterial isolates.

Sana Rahmani, Shaoli Basu, Patricia J Simner, Priti Kambli, Anjali Shetty, Camilla Rodrigues

Abstract read
In one paragraph

Article in The Indian journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sana RahmaniDepartment of Laboratory Medicine-Microbiology, Apollo Hospitals, Navi Mumbai, Maharashtra, India.
Shaoli BasuDepartment of Laboratory Medicine-Microbiology, P.D. Hinduja Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
Patricia J SimnerDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Minnesota, United States.
Priti KambliDepartment of Laboratory Medicine-Microbiology, P.D. Hinduja Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
Anjali ShettyDepartment of Laboratory Medicine-Microbiology, P.D. Hinduja Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
Camilla RodriguesDepartment of Laboratory Medicine-Microbiology, P.D. Hinduja Hospital and Medical Research Centre, Mumbai, Maharashtra, India.

Funding

CDC HHS 2005869446CDC HHS NU2GGH001869CDC HHS NU3HCK000001
6 · The paper itself

Abstract

Background & objectives Antimicrobial resistance has steadily become a grave public health problem worldwide, making carbapenems, often the last choice of antibiotic, for treating infections involving multidrug-resistant Gram-negative organisms. The production of carbapenemases is one of the primary mechanisms responsible for the development of resistance. KPC, NDM, VIM, IMP, and OXA-48-like are the most prevalent carbapenemases. Identification of CROs is based on the resistance phenotype or requires molecular assays, which are not widely available. A lateral flow assay (LFA) has been developed to enable rapid identification of carbapenemase production in cultured bacteria. Methods A total of 87 isolates characterised by Whole Genome Sequence (WGS) were tested. Five ATCC strains were used for quality control. LFA was performed according to the kit literature, and the results were compared with those by WGS. The assay was assessed for its sensitivity and specificity for the detection of five major carbapenemases. Results A total of 87 isolates of Enterobacterales and Pseudomonas aeruginosa, characterised by WGS, were tested. Of these, 52 were positive for the big five carbapenemases (IMP, VIM, KPC, NDM, and OXA-48-like), and 35 were negative. ATCC strains were run for quality control with each batch of tests. Overall sensitivity of the assay was 98.07 per cent (51/52), with no false positives, having 100 per cent specificity (35/35). The assay correctly detected strains producing KPC, OXA-48-like, VIM, and IMP, being 100 per cent sensitive (n=33/33) when compared with WGS results; whereas, it showed delayed positivity (>15 min) to identify one strain producing NDM-1 (thus considered false negative), accounting to sensitivity of 92.3 per cent (n=12/13) for detection of NDM. It correctly identified six strains simultaneously producing OXA-48-like and NDM, and one strain producing NDM-1 and KPC. Interpretation & conclusions The assay, being robust and cost-effective, with a short turn-around-time, will prove to be a great addition to the diagnostic armamentarium, helping in implementing antimicrobial stewardship and preventing AMR.

Indexed as

Bacterial Proteinsbeta-LactamasesPseudomonas aeruginosaAnti-Bacterial AgentsCarbapenemsDrug Resistance, Multiple, BacterialEnterobacteriaceaeGenotypeHumansMicrobial Sensitivity TestsWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsAnti-microbial resistancebig 5 carbapenemaseIMPKPClateral flow assayNDMOXA-48-likeVIM

Identifiers

PMID40878337
PMCPMC12550416

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.